Management of Upper Respiratory Tract Infections
Upper respiratory tract infections (URTIs) should be managed primarily with symptomatic treatment, with antibiotics reserved only for specific clinical scenarios suggesting bacterial infection. 1, 2
Diagnosis and Classification
- URTIs include the common cold, rhinosinusitis, pharyngitis, and acute otitis media, which are predominantly viral in origin 2
- Bacterial etiology should be suspected if symptoms persist >10 days, fever >39°C (102.2°F) is present, or symptoms worsen after initial improvement (double sickening) 1, 2
First-Line Management for Most URTIs
- Symptomatic treatment with analgesics for pain and antipyretics for fever is recommended for most uncomplicated URTIs 1, 2
- Saline nasal irrigation, topical or systemic decongestants, and intranasal corticosteroids may provide symptom relief 3
- Combination antihistamine-analgesic-decongestant products may provide symptom relief for approximately 25% of patients 3
- Treatment should be initiated early to reduce symptom severity and viral transmission 4
Antibiotic Use Guidelines
- Antibiotics are not recommended for viral URTIs as they will not prevent progression to lower respiratory tract infections 1
- For acute rhinosinusitis, antibiotics should be reserved for:
- When indicated for bacterial upper respiratory infections, amoxicillin is the drug of choice for susceptible (β-lactamase–negative) isolates of Streptococcus species, S. pneumoniae, Staphylococcus spp., or H. influenzae 6, 7
- Treatment with antibiotics should be continued for a minimum of 48 to 72 hours beyond symptom resolution 6
Specific URTI Management
Acute Pharyngitis
- Antibiotics for streptococcal pharyngitis should be prescribed only if test or culture results are positive 2, 5
- Penicillin V given in two daily doses is the treatment of choice for confirmed streptococcal infection 7
Acute Otitis Media
- Antibiotics are indicated for:
- Children younger than 6 months
- Children ages 6 to 23 months with bilateral AOM
- Children older than 2 years with bilateral AOM and otorrhea
- High-risk patients 2
- Amoxicillin is the drug of choice in regions with low penicillin resistance rates for S. pneumoniae 7
- Amoxicillin/clavulanate provides better coverage for treatment failures due to beta-lactamase producing H. influenzae and M. catarrhalis 7
Common Pitfalls to Avoid
- Overuse of antibiotics for viral URTIs, which provides no benefit and increases risk of adverse effects and antimicrobial resistance 3, 5
- Failure to recognize when a viral URTI has progressed to bacterial infection requiring different management 3
- Inappropriate use of homeopathic substances, including elderberry, which are not recommended for prevention or treatment of respiratory tract infections 1
- Neglecting proven supportive measures while relying on unproven therapies 3
Emerging Approaches
- Mucoadhesive gel nasal sprays may be beneficial for early intervention by creating a barrier that can trap virus particles, preventing invasion of the mucosa 4
- Judicious use of antibiotics based on accurate diagnosis of bacterial and non-bacterial conditions is essential to reduce antibiotic resistance 8